Cargando…
Are multiple physical symptoms a poor prognostic factor or just a marker of depression severity? Secondary analysis of the GenPod trial
BACKGROUND: Using data from the GenPod trial this study investigates: (i) if depressed individuals with multiple physical symptoms have a poorer response to antidepressants before and after adjustment for baseline Beck Depression Inventory II (BDI-II); and (ii) if reboxetine is more effective than c...
Autores principales: | Green, Amy, Crawford, Andrew, Button, Katherine S., Wiles, Nicola, Peters, Tim J., Nutt, David, Lewis, Glyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier/North-Holland Biomedical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315809/ https://www.ncbi.nlm.nih.gov/pubmed/24836086 http://dx.doi.org/10.1016/j.jad.2014.03.051 |
Ejemplares similares
-
GENetic and clinical Predictors Of treatment response in Depression: the GenPod randomised trial protocol
por: Thomas, Laura, et al.
Publicado: (2008) -
Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial
por: Gougoulaki, Marilia, et al.
Publicado: (2021) -
Allowing for non-adherence to treatment in a randomized controlled trial of
two antidepressants (citalopram versus reboxetine): an example from the
GENPOD trial
por: Wiles, N. J., et al.
Publicado: (2014) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals
por: Crawford, Andrew A., et al.
Publicado: (2014) -
How much change is enough? Evidence from a longitudinal study on depression in UK primary care
por: Kounali, Daphne, et al.
Publicado: (2022)